[go: up one dir, main page]

BR9610211A - Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato - Google Patents

Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato

Info

Publication number
BR9610211A
BR9610211A BR9610211-0A BR9610211A BR9610211A BR 9610211 A BR9610211 A BR 9610211A BR 9610211 A BR9610211 A BR 9610211A BR 9610211 A BR9610211 A BR 9610211A
Authority
BR
Brazil
Prior art keywords
meta
pharmaceutical compositions
compositions based
glyceryl poly
acrylate
Prior art date
Application number
BR9610211-0A
Other languages
English (en)
Inventor
Daniel Greff
Original Assignee
Stoa Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoa Sa filed Critical Stoa Sa
Priority to BR9610211-0A priority Critical patent/BR9610211A/pt
Publication of BR9610211A publication Critical patent/BR9610211A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção para "COMPOSIçõES FARMACEUTICAS BASEADAS EM GEL TIPO GLICERIL POLI(META) ACRILATO". A invenção revela o uso de composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato, localmente aplicadas para tratamento de vários sintomas e prevenção de certas condições patológicas: úlceras varicoses, secura e infecção vaginal (candidoses), scars, oedemas inflamatórios, mordidas de insetos, queimaduras leves, queimaduras pós-radioterapia, doenças virais (hérpes), doenças sexualmente transmitidas (em particular AIDS). Os géis são caracterizados por um pó de forte hidratação, uma capacidade de absorção muito alta, e segurança absoluta.
BR9610211-0A 1996-06-12 1996-06-12 Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato BR9610211A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9610211-0A BR9610211A (pt) 1996-06-12 1996-06-12 Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1996/000886 WO1997047310A1 (fr) 1996-06-12 1996-06-12 Compositions pharmaceutiques a base de gels de type glyceryl poly(meth)acrylate
BR9610211-0A BR9610211A (pt) 1996-06-12 1996-06-12 Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato

Publications (1)

Publication Number Publication Date
BR9610211A true BR9610211A (pt) 1999-12-21

Family

ID=9488483

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610211-0A BR9610211A (pt) 1996-06-12 1996-06-12 Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato

Country Status (6)

Country Link
EP (1) EP0843556A1 (pt)
JP (1) JPH11511180A (pt)
KR (1) KR19990036340A (pt)
AU (1) AU6309296A (pt)
BR (1) BR9610211A (pt)
WO (1) WO1997047310A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201585T1 (de) 1998-02-12 2001-06-15 Oreal Verwendung von 1,2-pentandiol in einer kosmetischen oder dermatologischen zusammensetzung, welche filmbildende polymerpartikel in wässriger dispersion enthält und kosmetische oder dermatologische zusammensetzung, enthaltend obige bestandteile
DE60143566D1 (de) * 2000-03-07 2011-01-13 Rush Presbyterian St Luke Zusammensetzungen und deren Verwendung zum Abfangen und Inaktivieren pathogener Mikroben und Spermatozoen
DK1363617T3 (da) * 2001-01-16 2009-01-26 Hans Brinch Lyster Cyanoacrylatsammensætninger til terapeutisk behandling af sår, som kræver revision
CA2463384A1 (en) * 2001-10-12 2003-04-17 Cns, Incorporated Hydrating nasal gel and applicator
EP1945307B1 (en) 2005-10-11 2013-03-27 DPT Laboratories, LTD. Surfactant-free dispersions, compositions, and use in topical formulations
FR2973701B1 (fr) 2011-04-06 2013-10-04 Biopass S A Composition pour application topique
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
FR3050640B1 (fr) * 2016-04-28 2020-02-21 Biopass Produit pharmaceutique
WO2021259215A1 (en) 2020-06-22 2021-12-30 Rht Limited Antiseptic compositions
US20230301884A1 (en) * 2020-06-22 2023-09-28 Rht Limited Antiseptic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
CA1305069C (en) * 1987-03-11 1992-07-14 John Cornell Wound dressings in sheet or gelled paste form
GB8910076D0 (en) * 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
GB9002290D0 (en) * 1990-02-01 1990-03-28 Procter & Gamble Cosmetic compositions
FR2682296B1 (fr) * 1991-10-14 1993-11-12 Sederma Sa Nouvelles compositions cosmetiques contenant des gels polymeriques.

Also Published As

Publication number Publication date
WO1997047310A1 (fr) 1997-12-18
JPH11511180A (ja) 1999-09-28
KR19990036340A (ko) 1999-05-25
EP0843556A1 (fr) 1998-05-27
AU6309296A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
BR9707325A (pt) Processo para o tratamento de um paciente afetado com uma doença mediada por il-1, composição farmacéutica e uso da mesma
ATE538177T1 (de) Wundgele
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR9910864A (pt) Compostos anti-inflamatórios para inibição de aderência celular
PT772600E (pt) Compostos de imidazolilo substituido nas posicoes 1 e 2 para o tratamento da inflamacao
FI972642L (fi) Galeeninen yksikkökoostumus käytettäväksi paikallisesti hedelmöityksen ehkäisyyn ja/tai sukupuoliteitse välittyvien sairauksien ja/tai HIV:n vastaiseen taisteluun
ES2182915T3 (es) Procedimiento de purificacion del factor viii
CA2293470A1 (en) Benzimidazole derivatives
ATE526956T1 (de) Viruzide zusammensetzungen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
DK1071439T3 (da) Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
BR9610211A (pt) Composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato
ATE316822T1 (de) Feste oder halbfeste kohlenwasserstoffgele
BR9509590A (pt) Aplicação de sod em liposomas
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
ATE111735T1 (de) Verwendung des wirkstoffs azelastin und glycerinethern zur bekämpfung von psoriasis- erkrankungen.
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
IS2860B (is) Veirueyðandi samsetningar
Fanta et al. Contact dermatitis from tromantadine hydrochloride.
ATE152356T1 (de) Topisches präparat zur besseren heilung von herpesverletzungen
WO1998046240A1 (en) Topical treatment of skin diseases and eye afflictions
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
KR880005920A (ko) 인체의 백혈구 인터페론 조성물과 피부 치료법
US5977176A (en) Compositions for the treatment of warts and herpes

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law